These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 33853106)

  • 1. Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain.
    García-Carmona JA; Simal-Aguado J; Campos-Navarro MP; Valdivia-Muñoz F; Galindo-Tovar A
    Int Clin Psychopharmacol; 2021 Jul; 36(4):201-207. PubMed ID: 33853106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness of Second Generation Long-acting Injectable Antipsychotics Based on Nationwide Database Research in Hungary: An Update.
    Takács P; Kunovszki P; Timtschenko V; Fehér L; Balázs T; Hegyi R; Czobor P; Bitter I
    Schizophr Bull Open; 2022 Jan; 3(1):sgac013. PubMed ID: 39144770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world effectiveness of long-acting injectable antipsychotic treatments in a nationwide cohort of 12,373 patients with schizophrenia-spectrum disorders.
    Boyer L; Falissard B; Nuss P; Collin C; Duret S; Rabbani M; De Chefdebien I; Tonelli I; Llorca PM; Fond G
    Mol Psychiatry; 2023 Sep; 28(9):3709-3716. PubMed ID: 37479781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysis.
    Wang D; Schneider-Thoma J; Siafis S; Qin M; Wu H; Zhu Y; Davis JM; Priller J; Leucht S
    Eur Neuropsychopharmacol; 2024 Jun; 83():11-18. PubMed ID: 38490016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-acting second-generation injectable antipsychotics for the maintenance treatment of bipolar disorder: a narrative review.
    Belge JB; Sabbe BGCC
    Expert Opin Pharmacother; 2024 Feb; 25(3):295-299. PubMed ID: 38465894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inpatient prescribing patterns of long-acting injectables and their oral or short-acting injectable equivalent formulations.
    Liu Y; Patterson ME; Sahil S; Stoner SC
    Front Pharmacol; 2023; 14():1140969. PubMed ID: 37284307
    [No Abstract]   [Full Text] [Related]  

  • 7. Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal.
    García-Carmona JA; Pappa S
    Drug Healthc Patient Saf; 2023; 15():113-123. PubMed ID: 37720806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of SGA-LAIs on Clinical, Cognitive, and Social Domains in Schizophrenia: Results from a Prospective Naturalistic Study.
    de Filippis R; Staltari FA; Aloi M; Carbone EA; Rania M; Destefano L; Steardo L; Segura-Garcia C; De Fazio P
    Brain Sci; 2023 Mar; 13(4):. PubMed ID: 37190542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of Second-Generation Antipsychotics in Patients with Severe Schizophrenia in the Real World: The Role of the Route of Administration and Dosage-A 5-Year Follow-Up.
    Fernández-Miranda JJ; Díaz-Fernández S; López-Muñoz F
    Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of long-acting antipsychotics in clinical practice : 1. A retrospective, 18-month follow up and comparison between paliperidone palmitate, risperidone long-acting injection and zuclopenthixol decanoate.
    Cordiner M; Shajahan P; McAvoy S; Bashir M; Taylor M
    Ther Adv Psychopharmacol; 2016 Feb; 6(1):22-32. PubMed ID: 26913175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability profile of paliperidone palmitate formulations: A pharmacovigilance analysis of the EUDRAVigilance database.
    Cicala G; de Filippis R; Barbieri MA; Cutroneo PM; De Fazio P; Schoretsanitis G; Spina E
    Front Psychiatry; 2023; 14():1130636. PubMed ID: 37091708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics-An Observational Study.
    Miron AA; Petric PS; Teodorescu A; Ifteni P; Chele G; Szalontay AS
    Brain Sci; 2023 Jan; 13(2):. PubMed ID: 36831716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of long-acting injectable antipsychotics versus oral antipsychotics on autonomic nervous system activity in schizophrenic patients.
    Suda A; Hattori S; Kishida I; Miyauchi M; Shiraishi Y; Fujibayashi M; Tsujita N; Ishii C; Ishii N; Moritani T; Hirayasu Y
    Neuropsychiatr Dis Treat; 2018; 14():2361-2366. PubMed ID: 30271152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of oral overlap with antipsychotic long-acting injectables initiated in an inpatient setting.
    Tran JT; Binger KJ; Miles TM
    Ment Health Clin; 2023 Jun; 13(3):147-151. PubMed ID: 37448828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-acting injectable antipsychotics for the treatment of bipolar disorder: evidence from mirror-image studies.
    Bartoli F; Cavaleri D; Nasti C; Palpella D; Guzzi P; Riboldi I; Crocamo C; Pappa S; Carrà G
    Ther Adv Psychopharmacol; 2023; 13():20451253231163682. PubMed ID: 36994116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors and metabolic syndrome in patients treated with long-acting injectables antipsychotics: a retrospective study.
    De Carlo V; Grancini B; Cassina N; Casati L; Piccoli E; Vismara M; Gobbo D; Zanaschi R; Lupo S; Olivieri S; Dell'Osso B
    Int Clin Psychopharmacol; 2023 May; 38(3):160-168. PubMed ID: 36729532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes.
    Fernández-Miranda JJ; Díaz-Fernández S; Cepeda-Piorno FJ; López-Muñoz F
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teetering on the Edge: Second-Degree Atrioventricular Block Following Long-Acting Second-Generation Antipsychotic.
    Harrisingh K; Cu C; Le ML; Benhayon D
    Cureus; 2023 Mar; 15(3):e36650. PubMed ID: 37101998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Acting Injectable Aqueous Suspensions-Summary From an AAPS Workshop.
    Holm R; Lee RW; Glassco J; DiFranco N; Bao Q; Burgess DJ; Lukacova V; Alidori S
    AAPS J; 2023 Apr; 25(3):49. PubMed ID: 37118621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The AAPS Journal Theme Issue: "Perspectives on Clinical Drug Development of Long-Acting Injectables".
    T'jollyn H; Ackaert O
    AAPS J; 2023 Nov; 25(6):104. PubMed ID: 37963990
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.